Literature DB >> 20534378

Long-term stability of soluble ST2 in frozen plasma samples.

Benjamin Dieplinger1, Margot Egger, Werner Poelz, Meinhard Haltmayer, Thomas Mueller.   

Abstract

OBJECTIVE: The aim of this study was to investigate the long-term in vitro stability of soluble ST2 (sST2). DESIGN AND METHODS: EDTA plasma samples were drawn from 15 individuals with various diseases. The Presage ST2 assay was used for measurement of sST2 concentrations directly after blood collection and after storing plasma samples for 18 months at -20 degrees C and -80 degrees C. The default criterion for analyte stability was set at 95%.
RESULTS: sST2 concentrations in the 15 individuals ranged from 12 U/mL to 140 U/mL. Directly after blood collection, the mean (+/-SD) sST2 concentration was 51+/-37 U/mL, and absolute analyte recoveries were 50+/-35 U/mL and 51+/-34 U/mL after storage of samples for 18 months at -20 degrees C and -80 degrees C, respectively. Relative analyte recoveries after 18 months of storage at -20 degrees C and -80 degrees C were 99+/-5% and 101+/-7%.
CONCLUSION: sST2 is stable for at least 1.5 years in plasma samples stored at -20 degrees C and -80 degrees C. Copyright (c) 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534378     DOI: 10.1016/j.clinbiochem.2010.05.019

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

1.  The effect of left ventricular remodelling on soluble ST2 in a cohort of hypertensive subjects.

Authors:  D B Ojji; L H Opie; S Lecour; L Lacerda; O M Adeyemi; K Sliwa
Journal:  J Hum Hypertens       Date:  2014-01-09       Impact factor: 3.012

2.  Soluble ST2: a new and promising activity marker in ulcerative colitis.

Authors:  David Díaz-Jiménez; Lucía E Núñez; Caroll J Beltrán; Enzo Candia; Cristóbal Suazo; Manuel Alvarez-Lobos; María-Julieta González; Marcela A Hermoso; Rodrigo Quera
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

3.  Design and Implementation of a Prospective Adult Congenital Heart Disease Biobank.

Authors:  Alexander R Opotowsky; Brittani Loukas; Christina Ellervik; Lilamarie E Moko; Michael N Singh; Elizabeth I Landzberg; Eric B Rimm; Michael J Landzberg
Journal:  World J Pediatr Congenit Heart Surg       Date:  2016-11

4.  Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population.

Authors:  Ravi H Parikh; Stephen L Seliger; Robert Christenson; John S Gottdiener; Bruce M Psaty; Christopher R deFilippi
Journal:  J Am Heart Assoc       Date:  2016-08-01       Impact factor: 5.501

5.  Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke.

Authors:  Zoe Wolcott; Ayush Batra; Matthew B Bevers; Cristina Sastre; Jane Khoury; Matthew Sperling; Brett C Meyer; Kyle B Walsh; Opeolu Adeoye; Joseph P Broderick; W Taylor Kimberly
Journal:  Ann Clin Transl Neurol       Date:  2017-07-05       Impact factor: 4.511

6.  Development of a Novel Homogeneous Nanoparticle-Based Assay for Rapid and High-Throughput Quantitation of the sST2 Protein in Human Serum.

Authors:  Shenxia Gao; Junpu Li
Journal:  Int J Nanomedicine       Date:  2020-12-30

7.  Relationship between left ventricular geometry and soluble ST2 in a cohort of hypertensive patients.

Authors:  Dike B Ojji; Lionel H Opie; Sandrine Lecour; Lydia Lacerda; Olusoji Adeyemi; Karen Sliwa
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-10-30       Impact factor: 3.738

8.  Soluble ST2 and Galectin-3: What We Know and Don't Know Analytically.

Authors:  Thomas Mueller; Benjamin Dieplinger
Journal:  EJIFCC       Date:  2016-08-01

9.  Prognostic value of soluble ST2 in adults with congenital heart disease.

Authors:  Laurie W Geenen; Vivan J M Baggen; Annemien E van den Bosch; Jannet A Eindhoven; Judith A A E Cuypers; Maarten Witsenburg; Eric Boersma; Jolien W Roos-Hesselink
Journal:  Heart       Date:  2019-01-30       Impact factor: 5.994

10.  N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors.

Authors:  Shruti Rajesh Patel; Joerg Herrmann; Robert A Vierkant; Janet E Olson; Fergus J Couch; Antonious Hazim; Jeff A Sloan; Charles L Loprinzi; Kathryn J Ruddy
Journal:  J Clin Med       Date:  2021-07-27       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.